Meeting Announcement for the Technical Advisory Panel on Medicare Trustee Reports, 8193-8194 [2017-01479]

Download as PDF sradovich on DSK3GMQ082PROD with NOTICES Federal Register / Vol. 82, No. 14 / Tuesday, January 24, 2017 / Notices the public. The Committee will discuss the nation’s health promotion and disease prevention objectives and will provide recommendations to improve health status and reduce health risks for the nation by the year 2030. The Committee will advise the Secretary on the Healthy People 2030 mission, vision, framework, and organizational structure. The Committee will provide advice regarding criteria for identifying a more focused set of measurable, nationally representative objectives. The Committee’s advice must assist the Secretary in reducing the number of objectives while ensuring that the selection criteria identifies the most critical public health issues that are high-impact priorities supported by current national data. DATES: The Committee will meet on February 13, 2017 from 12:00 p.m. to 4:00 p.m. Eastern Time (ET). ADDRESSES: The meeting will be held online, via the WebEx platform. To register to attend the meeting, please visit the Healthy People Web site at https://www.healthypeople.gov. FOR FURTHER INFORMATION CONTACT: Emmeline Ochiai, Designated Federal Officer, Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030, U.S. Department of Health and Human Services, Office of the Assistant Secretary for Health, Office of Disease Prevention and Health Promotion, 1101 Wootton Parkway, Room LL–100, Rockville, MD 20852, (240) 453–8280 (telephone), (240) 453–8281 (fax). Additional information is available on the Healthy People Web site at https:// www.healthypeople.gov. SUPPLEMENTARY INFORMATION: The names of the Committee members are available at https:// www.healthypeople.gov/2020/about/ history-development/healthy-people2030-advisory-committee. Purpose of Meeting: Through the Healthy People initiative, HHS leverages scientific insights and lessons from the past decade, along with new knowledge of current data, trends, and innovations, to develop the next iteration of national health promotion and disease prevention objectives. Healthy People provides science-based, 10-year national objectives for promoting health and preventing disease. Since 1979, Healthy People has set and monitored national health objectives that meet a broad range of health needs, encourage collaboration across sectors, guide individuals toward making informed health decisions, and measure the impact of our prevention and health promotion activities. Healthy People VerDate Sep<11>2014 19:36 Jan 23, 2017 Jkt 241001 2030 health objectives will reflect assessments of major risks to health and wellness, changing public health priorities, and emerging technologies related to our nation’s health preparedness and prevention. Public Participation at Meeting: Members of the public are invited to join the online Committee meeting. There will be no opportunity for oral public comments during this online Committee meeting. However, written comments are welcome throughout the entire development process of the national health promotion and disease prevention objectives for 2030 and may be emailed to HP2030@hhs.gov. To join the Committee meeting, individuals must pre-register at the Healthy People Web site at https:// www.healthypeople.gov. Participation in the meeting is limited. Registrations will be accepted until maximum webinar capacity is reached, and must be completed by 9:00 a.m. ET on February 13, 2017. A waiting list will be maintained should registrations exceed capacity, and those individuals will be contacted as additional space for the meeting becomes available. Registration questions may be directed to: Jim Nakayama at events@ nakamotogroup.com, or (240) 672–4011. Authority: 42 U.S.C. 217a. The Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030 is governed by provisions of the Federal Advisory Committee Act (FACA), Public Law 92–463, as amended (5 U.S.C., App.) which sets forth standards for the formation and use of federal advisory committees. Dated: January 12, 2017. Don Wright, Deputy Assistant Secretary for Health, Disease Prevention and Health Promotion. [FR Doc. 2017–01541 Filed 1–23–17; 8:45 am] BILLING CODE 4150–32–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting Announcement for the Technical Advisory Panel on Medicare Trustee Reports ACTION: Notice of Public Meeting. This notice announces the meeting dates for the Technical Advisory Panel on Medicare Trustee Reports on Tuesday, February 7, 2017 and Wednesday February 8, 2017 in Washington, DC. DATES: The meeting will be held on Tuesday, February 7, 2017 from 9:15 a.m. to 5:00 p.m. and Wednesday SUMMARY: PO 00000 Frm 00020 Fmt 4703 Sfmt 4703 8193 February 8, 2017, from 9:00 a.m. to 3:00 p.m. Eastern Time and it is open to the public. The meeting will be held at the Hubert Humphrey Building 200 Independence Ave. SW., Washington, DC, 20201 Room 738G.3. ADDRESSES: Dr. Donald Oellerich, Designated Federal Officer, at the Office of Human Services Policy, Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services, 200 Independence Ave. SW., Washington, DC 20201, (202) 690–8410. FOR FURTHER INFORMATION CONTACT: SUPPLEMENTARY INFORMATION: I. Purpose: The Panel will discuss the long-term rate of change in health spending and may make recommendations to the Secretary on how the Medicare Trustees might more accurately estimate health spending in the short and long run. The Panel’s discussion is expected to be very technical in nature and will focus on the actuarial and economic assumptions and methods by which Trustees might more accurately measure health spending. This Committee is governed by the provisions of the Federal Advisory Committee Act, as amended (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)). The Committee is composed of nine members appointed by the Assistant Secretary for Planning and Evaluation. II. Agenda. The Panel will likely hear presentations from two outside experts; one on prescription drugs spending and a second on spillover effects. In addition the HHS Office of the Actuary will present on issues the panel may wish to address. Additional presentations regarding long range growth, sustainability of provider payments under Affordable Care Act (ACA) and Medicare Access and Chip Reauthorization Act (MACRA), methods for transitioning from short term (10 year) to long term (75 year) projections and methods and the presentation of uncertainty in the report may follow. After any presentations, the Panel will deliberate openly on the topics. Interested persons may observe the deliberations, but the Panel will not hear public comments during this time. The Panel will also allow an open public session for any attendee to address issues specific to the topic. III. Meeting Attendance. The Tuesday, February 7, 2017 and Wednesday February 8, 2017 meetings are open to the public; however, in-person attendance is limited to space available. E:\FR\FM\24JAN1.SGM 24JAN1 8194 Federal Register / Vol. 82, No. 14 / Tuesday, January 24, 2017 / Notices Meeting Registration The public may attend the meeting inperson. Space is limited and registration is required in order to attend in-person. Registration may be completed by emailing or faxing all the following information to Dr. Donald Oellerich at don.oellerich@hhs.gov or fax 202–690– 6562: Name. Company name. Postal address. Email address. If sign language interpretation or other reasonable accommodation for a disability is needed, please contact Dr. Oellerich, no later than January 31, 2017 by sending an email message to don.oellerich@hhs.gov or calling 202– 690–8410. A confirmation email will be sent to the registrants shortly after completing the registration process. IV. Special Accommodations. Individuals requiring special accommodations must include the request for these services during registration. V. Copies of the Charter. The Secretary’s Charter for the Technical Advisory Panel on Medicare Trustee Reports is available upon request from Dr. Donald Oellerich at don.oellerich@ hhs.gov or by calling 202–690–8410. Dated: January 12, 2017. Kathryn E. Martin, Acting Assistant Secretary for Planning and Evaluation. [FR Doc. 2017–01479 Filed 1–23–17; 8:45 am] BILLING CODE 4150–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health sradovich on DSK3GMQ082PROD with NOTICES National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. VerDate Sep<11>2014 19:36 Jan 23, 2017 Jkt 241001 Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Peer Review Meeting. Date: February 21, 2017. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Susana Mendez, DVM, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room 3G53B, National Institutes of Health, NIAID, 5601 Fishers Lane Dr. MSC 9823, Bethesda, MD 20892–9823, (240) 669– 5077, mendezs@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Date: March 8, 2017. Time: 9:00 a.m. to 10:00 a.m. Agenda: To review and evaluate grant applications. Place: Office of Review, Division of Extramural Activities, National Inst of Nursing Research, National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Suite 703, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Mario Rinaudo, M.D., Scientific Review Officer, Office of Review, Division of Extramural Activities, National Inst of Nursing Research, National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Suite 703, Bethesda, MD 20892, 301–402–5807, mrinaudo@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.361, Nursing Research, National Institutes of Health, HHS) Dated: January 13, 2017. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. Dated: January 17, 2017. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–01457 Filed 1–23–17; 8:45 am] [FR Doc. 2017–01453 Filed 1–23–17; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institute of Nursing Research; Notice of Closed Meetings National Institute of Dental & Craniofacial Research; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Nursing Research Initial Review Group. Date: February 16–17, 2017. Time: 8:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20892. Contact Person: Weiqun Li, M.D., Scientific Review Officer, National Institute of Nursing Research, National Institutes of Health, 6701 Democracy Boulevard, Suite 703, Bethesda, MD 20892, 301–402–5807, wli@mail.nih.gov. Name of Committee: National Institute of Nursing Research Special Emphasis Panel; Loan Repayment. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; NIDCR Secondary Data Analysis. Date: February 22, 2017. Time: Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, Bethesda, MD 20814. Contact Person: GUO HE ZHANG, MPH, Ph.D., SCIENTIFIC REVIEW OFFICER, Scientific Review Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, 6701 Democracy Boulevard, Suite 672, Bethesda, MD 20892, zhanggu@mail.nih.gov. PO 00000 Frm 00021 Fmt 4703 Sfmt 4703 E:\FR\FM\24JAN1.SGM 24JAN1

Agencies

[Federal Register Volume 82, Number 14 (Tuesday, January 24, 2017)]
[Notices]
[Pages 8193-8194]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-01479]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting Announcement for the Technical Advisory Panel on Medicare 
Trustee Reports

ACTION: Notice of Public Meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces the meeting dates for the Technical 
Advisory Panel on Medicare Trustee Reports on Tuesday, February 7, 2017 
and Wednesday February 8, 2017 in Washington, DC.

DATES: The meeting will be held on Tuesday, February 7, 2017 from 9:15 
a.m. to 5:00 p.m. and Wednesday February 8, 2017, from 9:00 a.m. to 
3:00 p.m. Eastern Time and it is open to the public.

ADDRESSES: The meeting will be held at the Hubert Humphrey Building 200 
Independence Ave. SW., Washington, DC, 20201 Room 738G.3.

FOR FURTHER INFORMATION CONTACT: Dr. Donald Oellerich, Designated 
Federal Officer, at the Office of Human Services Policy, Assistant 
Secretary for Planning and Evaluation, U.S. Department of Health and 
Human Services, 200 Independence Ave. SW., Washington, DC 20201, (202) 
690-8410.

SUPPLEMENTARY INFORMATION: 
    I. Purpose: The Panel will discuss the long-term rate of change in 
health spending and may make recommendations to the Secretary on how 
the Medicare Trustees might more accurately estimate health spending in 
the short and long run. The Panel's discussion is expected to be very 
technical in nature and will focus on the actuarial and economic 
assumptions and methods by which Trustees might more accurately measure 
health spending. This Committee is governed by the provisions of the 
Federal Advisory Committee Act, as amended (5 U.S.C. App. 2, section 
10(a)(1) and (a)(2)). The Committee is composed of nine members 
appointed by the Assistant Secretary for Planning and Evaluation.
    II. Agenda. The Panel will likely hear presentations from two 
outside experts; one on prescription drugs spending and a second on 
spillover effects. In addition the HHS Office of the Actuary will 
present on issues the panel may wish to address. Additional 
presentations regarding long range growth, sustainability of provider 
payments under Affordable Care Act (ACA) and Medicare Access and Chip 
Reauthorization Act (MACRA), methods for transitioning from short term 
(10 year) to long term (75 year) projections and methods and the 
presentation of uncertainty in the report may follow. After any 
presentations, the Panel will deliberate openly on the topics. 
Interested persons may observe the deliberations, but the Panel will 
not hear public comments during this time. The Panel will also allow an 
open public session for any attendee to address issues specific to the 
topic.
    III. Meeting Attendance. The Tuesday, February 7, 2017 and 
Wednesday February 8, 2017 meetings are open to the public; however, 
in-person attendance is limited to space available.

[[Page 8194]]

Meeting Registration

    The public may attend the meeting in-person. Space is limited and 
registration is required in order to attend in-person. Registration may 
be completed by emailing or faxing all the following information to Dr. 
Donald Oellerich at don.oellerich@hhs.gov or fax 202-690-6562:

Name.
Company name.
Postal address.
Email address.

    If sign language interpretation or other reasonable accommodation 
for a disability is needed, please contact Dr. Oellerich, no later than 
January 31, 2017 by sending an email message to don.oellerich@hhs.gov 
or calling 202-690-8410.
    A confirmation email will be sent to the registrants shortly after 
completing the registration process.
    IV. Special Accommodations. Individuals requiring special 
accommodations must include the request for these services during 
registration.
    V. Copies of the Charter. The Secretary's Charter for the Technical 
Advisory Panel on Medicare Trustee Reports is available upon request 
from Dr. Donald Oellerich at don.oellerich@hhs.gov or by calling 202-
690-8410.

    Dated: January 12, 2017.
Kathryn E. Martin,
Acting Assistant Secretary for Planning and Evaluation.
[FR Doc. 2017-01479 Filed 1-23-17; 8:45 am]
 BILLING CODE 4150-05-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.